Source: Khaleej Times
A single dose of Pfizer and BioNtech’s Covid-19 vaccine has been found to cut the number of asymptomatic infections.
One million Covid vaccine doses administered in Wales
Source: The Guardian
Public Health Wales says more than 38% of adult population have received first dose Coronavirus – latest updates See all our coronavirus coverage One million doses of coronavirus vaccines have been administered in Wales, with more than one in three adults in the country receiving at least one dose. Data from Public Health Wales shows that more than 38% of the adult population, 916,316 people, have received their first dose of either the Pfizer/BioNTech or Oxford/AstraZeneca vaccine. So far, 89,053 people have received their second dose. Continue reading…
Asia Today: Hong Kong gets Pfizer vaccines as 2nd option
Source: ABC News
Over 500,000 doses of the Pfizer-BioNTech vaccine have arrived in Hong Kong following a two-day delay due to export procedures, offering a second inoculation option for the city
Kuwaiti Actor Dies After Receiving Pfizer Vaccine
Source: Tasnim News Agency
TEHRAN (Tasnim) – A Kuwaiti actor died of COVID-19 days after he received the first dose of the Pfizer-BioNTech vaccination.
Small Molecule Prefilled Syringes Market Expected To Grow By 2028: Industry Overview, Growth Drivers, Types And Applications With Forecast To 2026 | Pfizer, Inc., Sanofi S.A., Mylan N.V., Teva Pharmaceutical Industries Ltd
Source: OpenPR
Small molecule prefilled syringes are pharmaceutical preparations of small molecule drugs that are sold in prefilled syringes. Small molecule prefilled syringes are alternatives to other dosage forms such as tablets and capsules. Empty glass or plastic and polymer syringes are
It turns out we might need 3 coronavirus vaccine shots instead of 2 – here’s why
Source: BGR
As more contagious COVID variants spread across the US, Pfizer is exploring the utility of a third booster dose. Pfizer hopes that a third vaccine dose might “raise the antibody response 10 to 20 fold.
Canadian Pension Boss Quits After MidEast Trip For COVID Shot, Defying Govt Advice
Source: Zero Hedge
Canadian Pension Boss Quits After MidEast Trip For COVID Shot, Defying Govt Advice The head of Canada Pension Plan Investment Board (CPPIB), Mark Machin, has resigned after travelling to the United Arab Emirates to be vaccinated against COVID-19, flouting Canadian government’s travel advice and drawing criticism. Machin, 54, received Pfizer’s vaccine shot after arriving in the UAE with his partner this month , the Wall Street Journal reported on Thursday. According to the report, Machin has stayed on in the UAE and is due to receive his second dose in coming weeks. The UAE says it provides COVID-19 vaccinations to residents and citizens only, free of charge, and requires a valid residency identification card to receive the shots. It was not immediately clear how Machin, a British national, secured the vaccine by travelling to Dubai. After the incident involving Machin was exposed, he resigned, clearly under pressure from the political blowback. “The Deputy Prime Minister spoke to the Chair of the Board of Directors today and made clear that Canadians place their trust in the CPPIB and expect it to be held to a higher standard,” said Kat Cuplinskas, press secretary for Canada’s Ministry of Finance, Reuters reports.
Single Pfizer vaccine shot provides strong protection for those who’ve had Covid-19, UK studies suggest
Source: CNN
Just one dose of Pfizer/BioNTech’s coronavirus vaccine can induce a strong enough immune response in people who have already had Covid-19 that it could protect from future disease, according to two new papers published in the journal The Lancet on Thursday.
Ukraine to receive 10 million doses of Pfizer vaccine
Source: 112 International
Vaccine against Covid-19 will be transferred to Ukraine from the USA
J&J’s coronavirus shot could dramatically accelerate the US vaccine rollout. Here’s your new vaccination timeline.
Source: Business Insider
Summary List Placement A shot for every American. Political leaders and vaccine manufacturers have endeavored to meet this goal since the start of the pandemic, and it could finally become a reality this summer. An advisory committee to the Food and Drug Administration will vote Friday on whether to recommend Johnson & Johnson’s single-dose coronavirus shot for emergency authorization. An FDA review on Wednesday showed the shot is safe and effective against COVID-19 . If J&J’s shot gets the green light as expected, it will be the third coronavirus shot to be distributed across the US. Vaccines from Pfizer and Moderna have been administered to more than 45 million Americans thus far, though fewer than 21 million Americans have gotten the full two-dose regimen. Pfizer and Moderna have pledged to distribute 600 million doses to the US public by the end of July — enough to fully vaccinate 300 million people. J&J, meanwhile, has said it could deliver up to 100 million doses of its vaccine by the end of June.
